185 related articles for article (PubMed ID: 31394409)
1. Characterization of de novo lytic infection of dermal lymphatic microvascular endothelial cells by Kaposi's sarcoma-associated herpesvirus.
Golas G; Alonso JD; Toth Z
Virology; 2019 Oct; 536():27-31. PubMed ID: 31394409
[TBL] [Abstract][Full Text] [Related]
2. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
[TBL] [Abstract][Full Text] [Related]
3. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression.
Krishnan HH; Naranatt PP; Smith MS; Zeng L; Bloomer C; Chandran B
J Virol; 2004 Apr; 78(7):3601-20. PubMed ID: 15016882
[TBL] [Abstract][Full Text] [Related]
4. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
Purushothaman P; Thakker S; Verma SC
J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma-associated herpesvirus induces the ATM and H2AX DNA damage response early during de novo infection of primary endothelial cells, which play roles in latency establishment.
Singh VV; Dutta D; Ansari MA; Dutta S; Chandran B
J Virol; 2014 Mar; 88(5):2821-34. PubMed ID: 24352470
[TBL] [Abstract][Full Text] [Related]
6. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
7. The Lymphatic Cell Environment Promotes Kaposi Sarcoma Development by Prox1-Enhanced Productive Lytic Replication of Kaposi Sarcoma Herpes Virus.
Choi D; Park E; Kim KE; Jung E; Seong YJ; Zhao L; Madhavan S; Daghlian G; Lee HH; Daghlian PT; Daghlian S; Bui K; Koh CJ; Wong AK; Cho IT; Hong YK
Cancer Res; 2020 Aug; 80(15):3130-3144. PubMed ID: 32518204
[TBL] [Abstract][Full Text] [Related]
8. The Expression and Nuclear Retention Element of Polyadenylated Nuclear RNA Is Not Required for Productive Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.
Gutierrez IV; Dayton J; Harger S; Rossetto CC
J Virol; 2021 Jun; 95(13):e0009621. PubMed ID: 33853955
[TBL] [Abstract][Full Text] [Related]
9. KSHV genome harbors both constitutive and lytically induced enhancers.
Roy Chowdhury N; Gurevich V; Shamay M
J Virol; 2024 Jun; 98(6):e0017924. PubMed ID: 38695538
[TBL] [Abstract][Full Text] [Related]
10. Screening of the Human Kinome Identifies MSK1/2-CREB1 as an Essential Pathway Mediating Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication during Primary Infection.
Cheng F; Sawant TV; Lan K; Lu C; Jung JU; Gao SJ
J Virol; 2015 Sep; 89(18):9262-80. PubMed ID: 26109721
[TBL] [Abstract][Full Text] [Related]
11. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's sarcoma herpesvirus latency-associated nuclear antigen broadly regulates viral gene expression and is essential for lytic infection.
Li S; Wang M; Van Sciver N; Szymula A; Tumuluri VS; George A; Ramachandran A; Raina K; Costa CN; Zhao B; Kazemian M; Simas JP; Kaye KM
PLoS Pathog; 2024 Jan; 20(1):e1011907. PubMed ID: 38232124
[TBL] [Abstract][Full Text] [Related]
13. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M
J Virol; 2017 May; 91(10):. PubMed ID: 28275189
[TBL] [Abstract][Full Text] [Related]
14. Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures.
Ciufo DM; Cannon JS; Poole LJ; Wu FY; Murray P; Ambinder RF; Hayward GS
J Virol; 2001 Jun; 75(12):5614-26. PubMed ID: 11356969
[TBL] [Abstract][Full Text] [Related]
15. LANA-Mediated Recruitment of Host Polycomb Repressive Complexes onto the KSHV Genome during De Novo Infection.
Toth Z; Papp B; Brulois K; Choi YJ; Gao SJ; Jung JU
PLoS Pathog; 2016 Sep; 12(9):e1005878. PubMed ID: 27606464
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
Lan K; Kuppers DA; Verma SC; Robertson ES
J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
[TBL] [Abstract][Full Text] [Related]
17. iTIME.219: An Immortalized KSHV Infected Endothelial Cell Line Inducible by a KSHV-Specific Stimulus to Transition From Latency to Lytic Replication and Infectious Virus Release.
Dollery SJ; Maldonado TD; Brenner EA; Berger EA
Front Cell Infect Microbiol; 2021; 11():654396. PubMed ID: 33937098
[TBL] [Abstract][Full Text] [Related]
18. Kaposi's sarcoma-associated herpesvirus genome programming during the early stages of primary infection of peripheral blood mononuclear cells.
Jha HC; Lu J; Verma SC; Banerjee S; Mehta D; Robertson ES
mBio; 2014 Dec; 5(6):. PubMed ID: 25516617
[TBL] [Abstract][Full Text] [Related]
19. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency.
Lin X; Sun R; Zhang F; Gao Y; Bin L; Lan K
J Virol; 2017 Sep; 91(17):. PubMed ID: 28615201
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHV.
Naik NG; Nguyen TH; Roberts L; Fischer LT; Glickman K; Golas G; Papp B; Toth Z
PLoS Pathog; 2020 Jan; 16(1):e1008268. PubMed ID: 31923286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
